Qi A - Search Results

1

Human induced pluripotent stem cell-derived lung progenitor and alveolar epithelial cells attenuate hyperoxia-induced lung injury.

Shafa M, Ionescu LI, Vadivel A, Collins JJP, Xu L, Zhong S, Kang M, de Caen G, Daneshmand M, Shi J, Fu KZ, Qi A, Wang Y, Ellis J, Stanford WL, Thébaud B. Shafa M, et al. Among authors: qi a. Cytotherapy. 2018 Jan;20(1):108-125. doi: 10.1016/j.jcyt.2017.09.003. Epub 2017 Oct 20. Cytotherapy. 2018. PMID: 29056548

2

Uncoupling protein 2 deficiency mimics the effects of hypoxia and endoplasmic reticulum stress on mitochondria and triggers pseudohypoxic pulmonary vascular remodeling and pulmonary hypertension.

Dromparis P, Paulin R, Sutendra G, Qi AC, Bonnet S, Michelakis ED. Dromparis P, et al. Circ Res. 2013 Jul 5;113(2):126-36. doi: 10.1161/CIRCRESAHA.112.300699. Epub 2013 May 7. Circ Res. 2013. PMID: 23652801

3

Kinetics of electrophysiologic changes during oral loading of amiodarone and after withdrawal of amiodarone in the unsedated dog.

Tuna IC, Qi AC, Gornick C, Bolman RM 3rd, Benditt DG. Tuna IC, et al. Among authors: qi ac. Circulation. 1985 Dec;72(6):1380-5. doi: 10.1161/01.cir.72.6.1380. Circulation. 1985. PMID: 4064280

4

Comparison of indoor and outdoor atmospheric organophosphorus flame retardants (OPFRs) from the petrochemical industrial area in North China: occurrence, gas-PM_2.5 distribution, source appointment and health implications.

Gong F, Zhang T, Zhao T, Qi A, Xu P, Huang Q, Li Y, Wang M, Xiao Y, Yang L, Ji Y, Wang W. Gong F, et al. Among authors: qi a. Environ Pollut. 2024 Dec 12:125529. doi: 10.1016/j.envpol.2024.125529. Online ahead of print. Environ Pollut. 2024. PMID: 39674254

5

Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical Trial.

Collins SP, Shotwell MS, Strich JR, Gibbs KW, de Wit M, Files DC, Harkins M, Hudock K, Merck LH, Moskowitz A, Apodaca KD, Barksdale A, Safdar B, Javaheri A, Sturek JM, Schrager H, Iovine NM, Tiffany B, Douglas I, Levitt J, Ginde AA, Hager DN, Shapiro N, Duggal A, Khan A, Lanspa M, Chen P, Gentile N, Harris E, Gong M, Sellers S, Goodwin AJ, Tidswell MA, Filbin M, Desai N, Gutiérrez F, Estrada V, Burgos J, Boyles T, Paño-Pardo JR, Hussen N, Rosenberg Y, Troendle J, Bernard GR, Bistran-Hall AJ, Walsh K, Casey JD, DeClercq J, Joly MM, Pulley J, Rice TW, Schildcrout JS, Wang L, Semler MW, Self WH; ACTIV-4 Host Tissue Investigators. Collins SP, et al. JAMA Netw Open. 2024 Dec 2;7(12):e2448215. doi: 10.1001/jamanetworkopen.2024.48215. JAMA Netw Open. 2024. PMID: 39625722 Free PMC article. Clinical Trial.

6

The cannabinoid CB₂ receptor positive allosteric modulator EC21a exhibits complicated pharmacology in vitro.

Qi A, Han X, Quitalig M, Wu J, Christov PP, Jeon K, Jana S, Kim K, Engers DW, Lindsley CW, Rodriguez AL, Niswender CM. Qi A, et al. J Recept Signal Transduct Res. 2024 Aug;44(4):151-159. doi: 10.1080/10799893.2024.2431986. Epub 2024 Nov 22. J Recept Signal Transduct Res. 2024. PMID: 39575892

7

Genetic predisposition to acute lung injury in cardiac surgery 'The VEGF Factor': Review article and bibliometric analysis.

Yabo W, Dongxu L, Xiao L, Sandeep B, Qi A. Yabo W, et al. Among authors: qi a. Curr Probl Cardiol. 2025 Jan;50(1):102927. doi: 10.1016/j.cpcardiol.2024.102927. Epub 2024 Nov 6. Curr Probl Cardiol. 2025. PMID: 39510397 Review.

8

Research Progress on Epicardial Repair After Myocardial Injury.

Li G, Yan Z, Han L, Wu S, Wang M, Qi A, Zhou Z, Wang N, Sun R, Zhou X. Li G, et al. Among authors: qi a. Cardiol Rev. 2024 Nov 6. doi: 10.1097/CRD.0000000000000806. Online ahead of print. Cardiol Rev. 2024. PMID: 39503415

9

Efficacy of a WeChat-Based, Multidisciplinary, Full-Course Nutritional Management Program on the Nutritional Status of Patients With Ovarian Cancer Undergoing Chemotherapy: Randomized Controlled Trial.

Tian X, Liu Y, Zhang J, Yang L, Feng L, Qi A, Liu H, Liu P, Li Y. Tian X, et al. Among authors: qi a. JMIR Mhealth Uhealth. 2024 Nov 4;12:e56475. doi: 10.2196/56475. JMIR Mhealth Uhealth. 2024. PMID: 39496160 Free PMC article. Clinical Trial.

10

Silencing the lncRNA EBLN3P Improves Prognosis in Patients with Invasive Breast Cancer by Directly Targeting miR-144-3p.

Hu M, Zhang M, Qi X, Yuan L, Wu Z, Tian Y, Qi A. Hu M, et al. Among authors: qi a. J Environ Pathol Toxicol Oncol. 2025;44(1):1-9. doi: 10.1615/JEnvironPatholToxicolOncol.2024053299. J Environ Pathol Toxicol Oncol. 2025. PMID: 39462444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters